leucine has been researched along with Venous Thrombosis in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 6 (85.71) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Duan, J; Ji, X; Jiang, H; Li, M; Liu, L; Meng, R; Wei, H; Wu, Y; Xiao, X; Zhou, C; Zhou, Y | 1 |
| Ariëns, RA; Bertina, RM; Grant, PJ; Komanasin, N; Poort, SR; Rosendaal, FR; Van Hylckama Vlieg, A | 1 |
| Diz-Kucukkaya, R; Hancer, VS; Inanc, M; Nalcaci, M; Pekcelen, Y | 1 |
| Rosendaal, FR; Vossen, CY | 1 |
| Anderson, JL; Doucette, SP; Gagnon, F; Scarvelis, DK; Wells, PS | 1 |
| Anderson, JL; Carson, N; Doucette, SP; Grimwood, RL; Rodger, MA; Wells, PS | 1 |
| Billiemaz, K; Damon, G; Ibrahim, A; Rayet, I; Tardy, B; Teyssier, G | 1 |
1 review(s) available for leucine and Venous Thrombosis
| Article | Year |
|---|---|
Factor XIII Val34Leu variant is protective against venous thromboembolism: a HuGE review and meta-analysis.
Topics: Amino Acid Substitution; Factor XIII; Genetic Predisposition to Disease; Genetic Variation; Genotype; Humans; Leucine; Point Mutation; Polymorphism, Genetic; Risk Factors; Thromboembolism; Valine; Venous Thrombosis | 2006 |
6 other study(ies) available for leucine and Venous Thrombosis
| Article | Year |
|---|---|
Potential role of plasma branched-chain amino acids in the differential diagnosis of acute cerebral venous thrombosis.
Topics: Amino Acids, Branched-Chain; Biomarkers; Diagnosis, Differential; Humans; Isoleucine; Leucine; Valine; Venous Thrombosis | 2023 |
Factor XIII Val34Leu polymorphism, factor XIII antigen levels and activity and the risk of deep venous thrombosis.
Topics: Adolescent; Adult; Aged; Case-Control Studies; Factor XIII; Factor XIIIa; Female; Genotype; Humans; Leucine; Male; Middle Aged; Polymorphism, Genetic; Risk Factors; Valine; Venous Thrombosis | 2002 |
Factor XIII Val34Leu polymorphism does not contribute to the prevention of thrombotic complications in patients with antiphospholipid syndrome.
Topics: Adolescent; Adult; Antiphospholipid Syndrome; Factor XIII; Female; Gene Frequency; Genotype; Humans; Leucine; Male; Middle Aged; Polymorphism, Genetic; Venous Thrombosis | 2004 |
The protective effect of the factor XIII Val34Leu mutation on the risk of deep venous thrombosis is dependent on the fibrinogen level.
Topics: Adolescent; Adult; Aged; Blood Coagulation Tests; Case-Control Studies; Cross-Linking Reagents; Factor XIII; Female; Fibrinogen; Gene Frequency; Heterozygote; Homozygote; Humans; Leucine; Male; Middle Aged; Mutation; Odds Ratio; Risk; Valine; Venous Thrombosis | 2005 |
The factor XIII Val34Leu polymorphism: is it protective against idiopathic venous thromboembolism?
Topics: Amino Acid Substitution; Case-Control Studies; Factor XIII; Female; Genetic Predisposition to Disease; Genotype; Humans; Leucine; Male; Middle Aged; Odds Ratio; Polymorphism, Genetic; Risk Assessment; Thromboembolism; Valine; Venous Thrombosis; White People | 2006 |
[Heterozygous protein C deficiency: apropos of 2 cases with cerebral venous thrombosis in the neonatal period].
Topics: Cerebral Hemorrhage; Cerebral Veins; Follow-Up Studies; Heterozygote; Humans; Infant, Newborn; Intracranial Thrombosis; Leucine; Male; Mutation; Proline; Protein C; Protein C Deficiency; Renal Veins; Sinus Thrombosis, Intracranial; Treatment Outcome; Venous Thrombosis | 2000 |